Last reviewed · How we verify

Albumin Taxol

Fujian Medical University · Phase 3 active Small molecule

Albumin Taxol is a Taxane; microtubule stabilizer Small molecule drug developed by Fujian Medical University. It is currently in Phase 3 development for Metastatic breast cancer, Non-small cell lung cancer, Pancreatic cancer.

Albumin-bound paclitaxel (nab-paclitaxel) stabilizes microtubules by binding to β-tubulin, preventing their depolymerization and halting cell division.

Albumin-bound paclitaxel (nab-paclitaxel) stabilizes microtubules by binding to β-tubulin, preventing their depolymerization and halting cell division. Used for Metastatic breast cancer, Non-small cell lung cancer, Pancreatic cancer.

At a glance

Generic nameAlbumin Taxol
SponsorFujian Medical University
Drug classTaxane; microtubule stabilizer
Targetβ-tubulin
ModalitySmall molecule
Therapeutic areaOncology
PhasePhase 3

Mechanism of action

Paclitaxel is a taxane chemotherapy agent that binds to β-tubulin dimers within microtubules, preventing their disassembly and causing mitotic arrest. The albumin nanoparticle formulation improves drug delivery and reduces toxicity compared to conventional paclitaxel by enabling albumin-receptor-mediated endocytosis into tumor cells and reducing Cremophor EL-related hypersensitivity reactions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Albumin Taxol

What is Albumin Taxol?

Albumin Taxol is a Taxane; microtubule stabilizer drug developed by Fujian Medical University, indicated for Metastatic breast cancer, Non-small cell lung cancer, Pancreatic cancer.

How does Albumin Taxol work?

Albumin-bound paclitaxel (nab-paclitaxel) stabilizes microtubules by binding to β-tubulin, preventing their depolymerization and halting cell division.

What is Albumin Taxol used for?

Albumin Taxol is indicated for Metastatic breast cancer, Non-small cell lung cancer, Pancreatic cancer.

Who makes Albumin Taxol?

Albumin Taxol is developed by Fujian Medical University (see full Fujian Medical University pipeline at /company/fujian-medical-university).

What drug class is Albumin Taxol in?

Albumin Taxol belongs to the Taxane; microtubule stabilizer class. See all Taxane; microtubule stabilizer drugs at /class/taxane-microtubule-stabilizer.

What development phase is Albumin Taxol in?

Albumin Taxol is in Phase 3.

What are the side effects of Albumin Taxol?

Common side effects of Albumin Taxol include Neutropenia, Peripheral neuropathy, Anemia, Thrombocytopenia, Fatigue, Myalgia/arthralgia.

What does Albumin Taxol target?

Albumin Taxol targets β-tubulin and is a Taxane; microtubule stabilizer.

Related